Health & Wellness

An international meeting of Biogen managers last February likely helped spread Covid-19 far beyond Massachusetts to thousands of people in other states and overseas, a new genetic analysis found.

The Food and Drug Administration dismissed accusations that it authorized antibody-rich blood plasma for treating Covid-19 under White House pressure, after the president linked the pace of testing therapeutics to his re-election.

Some basic facts on convalescent plasma, a treatment for which the U.S. Food and Drug Administration has just authorized emergency use in certain Covid-19 patients.

The number of working Americans testing positive for drugs climbed last year, particularly for marijuana, indicating employee drug use was rising just as the coronavirus pandemic created new stresses.

The coronavirus pandemic has put the once-niche category of telemedicine in the spotlight and is now driving a flurry of deal activity involving virtual health-care providers.

Most child cases of Covid are mild. But some kids have longer-term symptoms such as headaches, shortness of breath and gastrointestinal problems.

A few years ago, I stopped taking care of myself after two kids, my father’s death and the end of my marriage took a toll. Then, I discovered bodybuilding—and my outlook on life changed.

A kind of drug that takes a page from a body’s natural antibody defenses may be able to give many people early protection against the coronavirus, ahead of vaccines.

The Trump administration is curtailing the Food and Drug Administration’s ability to regulate laboratory tests—including those for the new coronavirus—that have been developed by hundreds of hospitals.

Billions of dollars in federal funds earmarked for boosting nationwide Covid-19 testing remain unspent months after Congress made the money available, according to the U.S. Department of Health and Human Services.

The Department of Health and Human Services is reversing a recent change to the way hospitals report pandemic-related information to the government, again tasking the Centers for Disease Control and Prevention with data collection.

Donors raise $30 million for a psychedelic nonprofit to complete clinical trials around a drug-assisted psychotherapy for trauma.

A backlog of patients is growing at new clinics dedicated to Covid-19 survivors, known as long haulers, who continue to have symptoms many weeks or months after getting sick.

Johnson & Johnson agreed to buy Momenta Pharmaceuticals, giving J&J entry into a potentially big-selling new class of drugs to treat certain autoimmune diseases.

Roche has agreed to help manufacture and distribute a promising investigational drug—code named REGN-COV2—being developed by Regeneron, a pairing of rivals that could more than triple supplies of the medicine if it is authorized by regulators.

Latinos and Native Americans aged 25 to 34 died at a higher rate from the virus than peers from other ethnic groups.

A federal committee’s recommendation for new U.S. dietary guidelines comes on the heels of a 20-year rise in Americans’ drinking.

The French company has agreed to buy Principia Biopharma in a deal that values the developer of a promising multiple sclerosis treatment at $3.68 billion, the health-care giant’s latest move to focus more on specialty therapies over mass-market medicines.

Will I get sick? Will my teachers? How will class be different? We asked psychologists how parents can help their kids navigate returning to school.